A detailed history of Susquehanna Fundamental Investments, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 16,028 shares of IGMS stock, worth $152,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,028
Previous 27,731 42.2%
Holding current value
$152,105
Previous $268 Million 58.85%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$6.51 - $11.47 $76,186 - $134,233
-11,703 Reduced 42.2%
16,028 $110 Million
Q1 2024

May 07, 2024

BUY
$8.68 - $17.36 $240,705 - $481,410
27,731 New
27,731 $268 Million

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $275M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.